chemical chaperones reduce er stress restore glucose homeostasis mouse model type diabetes 
endoplasmic reticulum er stress key link obesity insulin resistance type diabetes provide evidence mechanistic link can exploited therapeutic purposes orally active chemical chaperones phenyl butyric acid taurine-conjugated ursodeoxycholic acid alleviated er stress cells whole animals treatment obese diabetic mice compounds resulted normalization hyperglycemia restoration systemic insulin sensitivity resolution fatty liver disease enhancement insulin action liver muscle adipose tissues results demonstrate chemical chaperones enhance adaptive capacity er act potent antidiabetic modalities potential application treatment type diabetes 
